BioTuesdays Feature Articles | Life Sciences News

Feature

Zenabis sets sights on becoming leading cannabis producer

By Len Zehr Despite being a new entrant in the cannabis market, Zenabis Global (TSX:ZENA) is making huge strides to become one of the largest licensed producers of medical and adult-use recreational cannabis in Canada...

June 11, 2019

Feature

Oragenics developing novel therapeutics using synthetic bacteria

By Abby Hardy Oragenics (NYSE American: OGEN) is leveraging its synthetic biology platforms to address two significant unmet medical needs: oral mucositis (OM) and multi drug-resistant (MDR) bacterial infections...

May 28, 2019

Feature

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

By Len Zehr BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) has reported impressive early safety and efficacy data with its lead immunotherapies for the treatment of advanced breast cancer. “Right now, there is no...

May 21, 2019

Feature

MediXall transforming patient-healthcare provider experience

By Len Zehr MediXall Group (OTCQB:MDXL) has launched a new generation healthcare marketplace platform to address self-pay and high deductible consumers’ growing need for greater healthcare cost transparency and access...

May 14, 2019

Feature

Ceapro transitioning to biopharmaceutical company from contract manufacturer

By Len Zehr Ceapro (TSXV:CZO) is transitioning to a new business model – from a contract manufacturer to a biopharmaceutical company – to pursue multiple growth opportunities in nutraceuticals and...

May 7, 2019

Feature

Leviticus Cardio developing wireless system to drive VADs

Michael Zilbershlag, Co-Founder and CEO By Len Zehr Closely-held Leviticus Cardio of Israel is developing a wireless system capable of providing day-to-day power needs for implanted ventricular assist devices (VADs)...

April 30, 2019

Feature

In conversation with Susan Linna of BDO

Susan Linna, Managing Director Life Sciences Specialty Services at BDO By Len Zehr As managing director, life sciences specialty services at BDO, the global professional services firm, Susan Linna has more than 25 years...

April 23, 2019

Feature

CellMax developing first blood test for CRC preventative screening

Padma Sundar, VP of Strategy and Market Access By Len Zehr Closely-held CellMax Life has developed FirstSightCRC, the first blood test to identify precancerous adenomas, with accuracy similar to colonoscopies, when...

April 16, 2019

Feature

BioSig unlocking future of bioelectronic medicine through signal processing

Kenneth Londoner, Founder, Chairman and CEO By Len Zehr With the FDA’s 510(k) clearance of its PURE EP System in August 2018 and first successful patient cases, BioSig (NASDAQ:BSGM) is advancing its vision to improve...

April 9, 2019

Feature

NuPulseCV evaluating new intravascular ventricular assist system

By Len Zehr Closely-held NuPulseCV is enrolling patients with advanced heart failure in a feasibility study with its intravascular ventricular assist system (iVAS), a minimally invasive heart pump designed to allow...

April 2, 2019

Feature

Vessi Medical developing new treatment for superficial bladder cancer

By Len Zehr Closely-held Vessi Medical wants to change the standard of care for superficial bladder cancer by using a surface cryotherapy approach in a minimally invasive in-office treatment alternative to surgery. “We...

March 26, 2019

Feature

Corindus banking on telerobotics potential to treat stroke

By Len Zehr After recently conducting five first-in-man coronary stent procedures robotically in India, Corindus Vascular Robotics (NASDAQ:CVRS) plans to perform its first remote vascular cases in the U.S. in mid-2019...

March 19, 2019

Feature

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

By Len Zehr Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene...

March 12, 2019

Feature

In Conversation with Gregory Montalbano of MIDI

By Len Zehr As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience...

March 5, 2019

Feature

PharmaJet injection devices creating needle-free world

By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...

February 26, 2019

Feature

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

By Len Zehr Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental...

February 19, 2019

Feature

ImpediMed sees revenue upswing from new SaaS business model

ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.

February 12, 2019

Feature

Interface Biologics to focus future growth in biotech with local drug delivery platform

Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on...

February 5, 2019

Feature

Karius diagnostic test enabling precision medicine for infectious diseases

Closely-held Karius has developed and commercialized a next-generation sequencing test that can identify and quantify microbial cell-free DNA from more than 1,300 bacteria, viruses, fungi and parasites using a non...

January 29, 2019

Feature

Novavax to report key vaccine data in first quarter

Novavax (NASDAQ:NVAX) is scheduled to report pivotal data in the current quarter for ResVax, its RSV (respiratory syncytial virus) F vaccine, using aluminum phosphate as an adjuvant, in infants via maternal immunization.

January 22, 2019

Feature

Titan Pharma relaunch of Probuphine paying early dividends

Titan Pharmaceuticals’ (NASDAQ:TTNP) relaunch of its Probuphine implant for the long-term maintenance treatment of opioid use disorder (OUD) demonstrated promising results with a meaningful increase in product shipments...

January 15, 2019

Feature

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

BeyondSpring (NASDAQ:BYSI) is preparing to file NDAs with the China FDA during the next six months for its lead asset, first-in-class agent Plinabulin, for the treatment of non-small cell lung cancer (NSCLC) and...

January 8, 2019

Zenabis sets sights on becoming leading cannabis producer

Oragenics developing novel therapeutics using synthetic bacteria

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

MediXall transforming patient-healthcare provider experience

Ceapro transitioning to biopharmaceutical company from contract manufacturer

Leviticus Cardio developing wireless system to drive VADs

In conversation with Susan Linna of BDO

CellMax developing first blood test for CRC preventative screening

BioSig unlocking future of bioelectronic medicine through signal processing

NuPulseCV evaluating new intravascular ventricular assist system

Vessi Medical developing new treatment for superficial bladder cancer

Corindus banking on telerobotics potential to treat stroke

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

In Conversation with Gregory Montalbano of MIDI

PharmaJet injection devices creating needle-free world

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

ImpediMed sees revenue upswing from new SaaS business model

Interface Biologics to focus future growth in biotech with local drug delivery platform

Karius diagnostic test enabling precision medicine for infectious diseases

Novavax to report key vaccine data in first quarter

Titan Pharma relaunch of Probuphine paying early dividends

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

General

More